The German DAX 30 index may lose ground in the near term on the back of the delayed ratification of the EU Recovery Fund and Chancellor Merkel’s ban on AstraZeneca’s Covid-19 vaccine.
The German DAX 30 index may lose ground in the near term on the back of the delayed ratification of the EU Recovery Fund and Chancellor Merkel’s ban on AstraZeneca’s Covid-19 vaccine.